PRR23B inhibitors represent a class of chemical compounds that target the PRR23B protein, a member of the proline-rich 23 family. This protein is notable for its involvement in cellular processes that are not fully elucidated but appear to influence signaling pathways and gene regulation. Structurally, PRR23B inhibitors are often characterized by their ability to interact with specific domains of the PRR23B protein, particularly those containing proline-rich motifs. These motifs serve as docking sites for proteins involved in signaling and regulatory functions, making them important for intracellular communication. The binding of an inhibitor to PRR23B alters its conformation, potentially preventing it from associating with other molecules or executing its normal biological role within the cell. Such inhibitors are developed based on an understanding of the protein's structural domains, typically focusing on regions where small molecules or peptides can disrupt interactions critical for the protein's function.
The design and optimization of PRR23B inhibitors generally follow standard principles of chemical inhibition. These compounds are often identified through high-throughput screening of molecular libraries or rational drug design, using computational models to predict interactions at the atomic level. Inhibitors of PRR23B must exhibit high selectivity to avoid off-target effects on similar proteins or proline-rich regions found in other molecular contexts. Researchers analyze binding affinities, solubility, and metabolic stability to enhance the efficacy of these inhibitors. The exploration of PRR23B inhibitors involves meticulous studies on their chemical composition, including structure-activity relationships (SAR), where small structural modifications can significantly alter their binding capacity and potency. This field of study continues to expand as new methods for targeting protein interactions, such as allosteric inhibition, are explored, providing valuable insights into the broader roles of PRR23B in cell biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzyl isothiocyanate | 622-78-6 | sc-204641 sc-204641A | 5 g 25 g | $46.00 $153.00 | 1 | |
Inhibits proline-rich motifs from interacting with SH3 domains, which could inhibit Proline-rich protein 23B by preventing its interactions with other proteins that rely on proline-rich binding domains. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, a kinase that phosphorylates many proteins, including proline-rich proteins. The inhibition of GSK-3 could prevent the phosphorylation of Proline-rich protein 23B, thus inhibiting its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is upstream in the MAPK/ERK pathway. Proline-rich protein 23B, involved in signal transduction, could be functionally inhibited due to the blockade of this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, potentially inhibiting Proline-rich protein 23B by blocking the downstream signaling that may be necessary for its full activation or function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which might alter the signaling pathways that Proline-rich protein 23B is involved in, leading to its functional inhibition. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK kinase, which could lead to the inhibition of Proline-rich protein 23B if the protein's function is dependent on actin cytoskeleton dynamics influenced by ROCK. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Inhibits tyrosine kinases, which could lead to the inhibition of Proline-rich protein 23B by preventing phosphorylation events crucial for its function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Inhibits Src family kinases, potentially inhibiting Proline-rich protein 23B by blocking phosphorylation and subsequent activation of signaling pathways it's involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially inhibiting Proline-rich protein 23B by preventing the activation of downstream signals required for its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K and could inhibit Proline-rich protein 23B by blocking the PI3K/AKT pathway, affecting processes the protein may be involved in. | ||||||